Compugroup Medspadr 1 Stock Price To Book
| COPA Stock | EUR 21.20 0.40 1.85% |
COMPUGROUP MEDSPADR 1 fundamentals help investors to digest information that contributes to COMPUGROUP MEDSPADR's financial success or failures. It also enables traders to predict the movement of COMPUGROUP Stock. The fundamental analysis module provides a way to measure COMPUGROUP MEDSPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COMPUGROUP MEDSPADR stock.
COMPUGROUP |
COMPUGROUP MEDSPADR 1 Company Price To Book Analysis
COMPUGROUP MEDSPADR's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, COMPUGROUP MEDSPADR 1 has a Price To Book of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Health Information Services (which currently averages 0.0) industry. The price to book for all Germany stocks is 100.0% higher than that of the company.
COMPUGROUP Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COMPUGROUP MEDSPADR's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of COMPUGROUP MEDSPADR could also be used in its relative valuation, which is a method of valuing COMPUGROUP MEDSPADR by comparing valuation metrics of similar companies.COMPUGROUP MEDSPADR is currently under evaluation in price to book category among its peers.
COMPUGROUP Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.031 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 53.50 X | |||
| Revenue | 1.13 B | |||
| Gross Profit | 373.55 M | |||
| EBITDA | 149.63 M | |||
| Net Income | 72.32 M | |||
| Cash And Equivalents | 91.45 M | |||
| Cash Per Share | 1.73 X | |||
| Total Debt | 685.04 M | |||
| Debt To Equity | 1.19 % | |||
| Current Ratio | 0.91 X | |||
| Book Value Per Share | 12.98 X | |||
| Cash Flow From Operations | 165.54 M | |||
| Earnings Per Share | 1.37 X | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 2.72 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.5 |
About COMPUGROUP MEDSPADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze COMPUGROUP MEDSPADR 1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of COMPUGROUP MEDSPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of COMPUGROUP MEDSPADR 1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in COMPUGROUP Stock
COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.